Throughout the study, changes in appendicular lean mass did not achieve significance in either of the bimagrumab groups compared with placebo.
← all excerpts
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort.
1
—
—